Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute mycardial infarction receiving thrombolytic therapy

Journal of the American College of Cardiology

Volumn 22, Issue 2, 1993, Pages 407-416

  Van De Werf, Frans ^a   Janssens, Luc ^a   Brzostek, Thomasz ^a   Mortelmans, Luc ^a   Wackers, J T H ^c   Willems, Georges M ^b   HeidbÜchel, Hein ^a   Lesaffre, Emmanuel ^a   Scheys, Ilse ^a   Collen, Désiré ^a   De Geest, Hilaire ^a  

^a Departments of Cardiology Nuclear Medicine and Biostatistics the Center for Thrombosis and Vascular Research ^*  (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALINIDINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; FEMALE; HEART ARRHYTHMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; ARRHYTHMIA; ATENOLOL; CARDIOVASCULAR AGENTS; CLONIDINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EXERCISE TEST; FEMALE; HUMAN; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; SUPPORT, NON-U.S. GOV'T; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VASCULAR PATENCY; VENTRICULAR FUNCTION, LEFT;

EID: 0027199167     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(93)90044-2     Document Type: Article

References (41)

1. Overview of results of randomized clinical trials in heart disease
2. Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol)
3. Effects of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs
4. Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with β-adrenergic blockade with metoprolol
5. Coronary artery thrombosis and thrombolysis in baboons: the effect of atenolol treatment on myocardial infarct size
6. Coronary reperfusion by thrombolysis and early β-adrenergic blockade in acute experimental myocardial infarction
7. Acute effects of parenteral beta-blockade on regional ventricular function of infarct and noninfarct zone after reperfusion therapy in humans
8. Immediate versus deferred β-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B study
9. Intravenous atenolol + streptokinase versus streptokinase alone in acute myocardial infarction: a pilot randomized cooperative study (abstr)
10. Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis
11. Mechanism of beneficial effect of β-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs
12. Cardiovascular actions of N-allylclornidine (ST 567), a substance with specific bradycardiac action
13. Randomized trial of intravenous streptokinase oral aspirin both or neither among 17187 cases of suspected acute myocardial infarction ISIS-2
14. Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum α-hydroxybutyrate dehydrogenase levels
15. A rapid enzymatic method for assay of fibrinogen: the fibrin polymerization test (F.P.T.)
16. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA
17. Effect of aging on the pharmacokinetics of atenolol, metaprolol and propranolol in the rat
18. Development of quality control of a highly sensitive radioimmunoassay for alinidine
19. Coronary thrombolysis with recombinant tissue-type plasminogen activator: patency rate and regional wall motion after 3 months
20. The Thrombolysis in Myocardial Infarction (TIMI) trial
21. The use of single plane angiograms for the calculations of the left ventricular volume in man
22. Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase
23. Advantages and applications of the centerline method for characterizing regional ventricular function
24. Serial quantitative planar technetium-99m Isonitrile imaging in acute myocardial infarction efficacy for noninvasive assessment of thrombolytic therapy
25. Model-based quantification of myocardial perfusion images
26. The effect of inotropic stimulation on normal and ischemic myocardium after coronary occlusion
27. Response of reperfusion-salvaged stunned myocardium to inotropic stimulation
28. β-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration
29. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation
30. The assessment of contractile reserve after thrombolytic therapy for acute myocardial infarction
31. Should β-blockers be given immediately and concomitantly with thrombolytic therapy in acute myocardial infarction
32. β-blockade during and after myocardial infarction: an overview of the randomized trials
33. Can β-blockers limit myocardial infarct size?
34. Mechanisms for the early mortality reduction produced by β-blockade started early in acute myocardial infarction ISIS-1
35. Antiarrhythmic action of specific bradycardiac agents
36. Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary artery disease: potential effects of β-blockade
37. Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis
38. Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial with alteplase (rt-PA)
39. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment
40. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol